Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9205942 [patent_doc_number] => 20140005119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/931263 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16558 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931263 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/931263
COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVITY OF P110a MUTANT PROTEINS Jun 27, 2013 Abandoned
Array ( [id] => 9269630 [patent_doc_number] => 20140024548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS' [patent_app_type] => utility [patent_app_number] => 13/923316 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 47707 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923316 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/923316
DRUG SELECTION FOR MALIGNANT CANCER THERAPY USING ANTIBODY-BASED ARRAYS Jun 19, 2013 Abandoned
Array ( [id] => 9462778 [patent_doc_number] => 20140127205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-08 [patent_title] => 'Synthetic scFv Analogue To The 6313/G2 (Anti Angiotensin II Type 1 Receptor) Monoclonal Antibody Variable Regions' [patent_app_type] => utility [patent_app_number] => 13/923194 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10162 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923194 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/923194
Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions Jun 19, 2013 Issued
Array ( [id] => 9761719 [patent_doc_number] => 08846038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Method for treating synovial sarcoma' [patent_app_type] => utility [patent_app_number] => 13/918599 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 29 [patent_no_of_words] => 29307 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918599 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/918599
Method for treating synovial sarcoma Jun 13, 2013 Issued
Array ( [id] => 9108370 [patent_doc_number] => 20130281502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'POST-TREATMENT BREAST CANCER PROGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/914617 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11568 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914617 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/914617
POST-TREATMENT BREAST CANCER PROGNOSIS Jun 9, 2013 Abandoned
Array ( [id] => 11785955 [patent_doc_number] => 09395368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors' [patent_app_type] => utility [patent_app_number] => 13/914112 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 44 [patent_no_of_words] => 28990 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914112 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/914112
Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors Jun 9, 2013 Issued
Array ( [id] => 10040318 [patent_doc_number] => 09081019 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95' [patent_app_type] => utility [patent_app_number] => 13/911329 [patent_app_country] => US [patent_app_date] => 2013-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 21 [patent_no_of_words] => 28922 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911329 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/911329
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 Jun 5, 2013 Issued
Array ( [id] => 9295203 [patent_doc_number] => 20140038837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/909022 [patent_app_country] => US [patent_app_date] => 2013-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18431 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909022 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/909022
BIOMARKERS FOR THE DETECTION OF EARLY STAGE OVARIAN CANCER Jun 2, 2013 Abandoned
Array ( [id] => 9262138 [patent_doc_number] => 20130344067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/907798 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20190 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907798 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/907798
ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF May 30, 2013 Abandoned
Array ( [id] => 9173835 [patent_doc_number] => 20130315819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS' [patent_app_type] => utility [patent_app_number] => 13/904039 [patent_app_country] => US [patent_app_date] => 2013-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 99 [patent_no_of_words] => 129473 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904039 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/904039
POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS May 28, 2013 Abandoned
Array ( [id] => 16197440 [patent_doc_number] => 10722577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Methods for treating GI syndrome and graft versus host disease [patent_app_type] => utility [patent_app_number] => 14/402875 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 14089 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402875 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402875
Methods for treating GI syndrome and graft versus host disease May 27, 2013 Issued
Array ( [id] => 12527010 [patent_doc_number] => 10005846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Anti-transglutaminase 2 antibodies [patent_app_type] => utility [patent_app_number] => 14/402675 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 47 [patent_no_of_words] => 36206 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402675 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/402675
Anti-transglutaminase 2 antibodies May 23, 2013 Issued
Array ( [id] => 9173914 [patent_doc_number] => 20130315899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/901050 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27743 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901050 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/901050
METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS May 22, 2013 Abandoned
Array ( [id] => 12948601 [patent_doc_number] => 09835636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells [patent_app_type] => utility [patent_app_number] => 13/892011 [patent_app_country] => US [patent_app_date] => 2013-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 4250 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13892011 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/892011
Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells May 9, 2013 Issued
Array ( [id] => 9003623 [patent_doc_number] => 20130224748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/890098 [patent_app_country] => US [patent_app_date] => 2013-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26619 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13890098 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/890098
METHODS AND COMPOSITIONS FOR DETECTING ENDOMETRIAL OR OVARIAN CANCER May 7, 2013 Abandoned
Array ( [id] => 11930915 [patent_doc_number] => 09797906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Detectors of serum biomarkers for predicting ovarian cancer recurrence' [patent_app_type] => utility [patent_app_number] => 14/398773 [patent_app_country] => US [patent_app_date] => 2013-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 12795 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398773 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/398773
Detectors of serum biomarkers for predicting ovarian cancer recurrence May 5, 2013 Issued
Array ( [id] => 11596851 [patent_doc_number] => 09644003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-09 [patent_title] => 'RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof' [patent_app_type] => utility [patent_app_number] => 14/397539 [patent_app_country] => US [patent_app_date] => 2013-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6472 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397539 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/397539
RTN4B polypeptide, monoclonal antibody thereof, monoclonal antibody-producing hybridoma cell strain, and, preparation and application thereof May 5, 2013 Issued
Array ( [id] => 11699968 [patent_doc_number] => 09689876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Methods related to cancer treatment' [patent_app_type] => utility [patent_app_number] => 14/398377 [patent_app_country] => US [patent_app_date] => 2013-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18141 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398377 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/398377
Methods related to cancer treatment Apr 30, 2013 Issued
Array ( [id] => 9518187 [patent_doc_number] => 20140154680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/873487 [patent_app_country] => US [patent_app_date] => 2013-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18162 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13873487 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/873487
DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER Apr 29, 2013 Abandoned
Array ( [id] => 9408053 [patent_doc_number] => 20140099305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/865902 [patent_app_country] => US [patent_app_date] => 2013-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15834 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865902 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/865902
COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY Apr 17, 2013 Abandoned
Menu